BOSTON--(BUSINESS WIRE)--Averion International Corp. (OTCBB:AVRO) and Brazil-based BIOCANCER today announced the signing of a non-exclusive agreement to jointly market and contract complementary services to biotechnology, pharmaceutical and medical device companies. BIOCANCER is a full-service site management and clinical research organization (CRO) with a focus on oncology.
